Geode Capital Management
NUVB icon

Geode Capital Management’s Nuvation Bio NUVB Stock Holding History

Geode Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5M Buy
6,244,805
+381,151
+7% +$1.86M ﹤0.01% 1822
2026
Q1 		$25.2M Buy
5,863,654
+151,358
+3% +$843K ﹤0.01% 1873
2025
Q4 		$51.2M Sell
5,712,296
-175,459
-3% -$1.09M ﹤0.01% 1462
2025
Q3 		$21.8M Sell
5,887,755
-107,043
-2% -$292K ﹤0.01% 1956
2025
Q2 		$11.7M Buy
5,994,798
+864,194
+17% +$1.8M ﹤0.01% 2256
2025
Q1 		$9.03M Buy
5,130,604
+179,409
+4% +$408K ﹤0.01% 2353
2024
Q4 		$13.2M Buy
4,951,195
+922,503
+23% +$2.38M ﹤0.01% 2188
2024
Q3 		$9.23M Buy
4,028,692
+196,247
+5% +$599K ﹤0.01% 2432
2024
Q2 		$11.2M Buy
3,832,445
+705,247
+23% +$2.15M ﹤0.01% 2251
2024
Q1 		$11.4M Buy
3,127,198
+80,873
+3% +$155K ﹤0.01% 2254
2023
Q4 		$4.6M Buy
3,046,325
+146,203
+5% +$188K ﹤0.01% 2748
2023
Q3 		$3.89M Buy
2,900,122
+169,412
+6% +$282K ﹤0.01% 2768
2023
Q2 		$4.92M Buy
2,730,710
+342,435
+14% +$582K ﹤0.01% 2682
2023
Q1 		$3.96M Buy
2,388,275
+69,241
+3% +$140K ﹤0.01% 2737
2022
Q4 		$4.45M Buy
2,319,034
+45,718
+2% +$92.5K ﹤0.01% 2725
2022
Q3 		$5.09M Buy
2,273,316
+270,082
+13% +$771K ﹤0.01% 2668
2022
Q2 		$6.49M Sell
2,003,234
-270,237
-12% -$1.18M ﹤0.01% 2551
2022
Q1 		$12M Buy
2,273,471
+115,891
+5% +$651K ﹤0.01% 2235
2021
Q4 		$18.3M Buy
2,157,580
+748,225
+53% +$6.88M ﹤0.01% 2011
2021
Q3 		$14M Buy
1,409,355
+605,416
+75% +$5.49M ﹤0.01% 2211
2021
Q2 		$7.48M Buy
803,939
+282,357
+54% +$3.22M ﹤0.01% 2660
2021
Q1 		$5.45M Buy
+521,582
New +$5.83M ﹤0.01% 2752

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management's NUVB Position: Q2 2026 in Review

Geode Capital Management increased its Nuvation Bio (NUVB) stake by 6.5% in Q2 2026, buying an estimated $1.86M and bringing the position to 6,244,805 shares worth $35.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Geode Capital Management first reported a position in NUVB in Q1 2021 and has held it in 22 quarters since. The position peaked at $51.2M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Geode Capital Management held 6,244,805 shares of Nuvation Bio worth $35.5M as of Q2 2026.
  • Geode Capital Management bought 381,151 Nuvation Bio shares in Q2 2026, an estimated $1.86M.
  • Nuvation Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1822 holding.
  • Geode Capital Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 22 quarters since.
  • Geode Capital Management's Nuvation Bio position peaked at $51.2M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.